The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.
The strategy has had a mixed month so far, with most of those highlighted seeing share price declines. Particularly noticeable was AstraZeneca, down 8.75% after the Pfizer bid was kicked into the long grass (for now, at least). This indicates an important consideration – some of those shares with a strong performance will have been bolstered by bid talk, and if the bid talk ceases the rally in the share price can rapidly evaporate.